Is biopharmaceuticals in China a state-owned enterprise or a private enterprise?

China Biopharmaceutical is a private enterprise. According to the national enterprise credit information publicity system inquired by official website who, headquartered in Hongkong, China and Peking, it is a comprehensive pharmaceutical enterprise and a family-controlled private enterprise. Its main business is drug research and development, production and sales, and drugs are mainly imitations. China Bio-Pharmaceutical Co., Ltd. (hereinafter referred to as "China Bio-Pharmaceutical") is a leading innovative research and R&D-driven pharmaceutical group in China, covering the whole industrial chain platform of pharmaceutical R&D, intelligent production and powerful sales system. The company was listed on China Hong Kong Stock Exchange in 2000, and was selected as a component of MSCI Global Standard Index China Index in 20 13. 20 18 was selected as a constituent stock of the hang seng index; 20 19 was selected as a constituent stock of the Hang Seng China Enterprises Index; In 2020, it was selected as a component of the Biotechnology 50 Index of Hang Seng Shanghai-Shenzhen-Hong Kong Stock Connect and the 25 Index of Hang Seng China (listed in Hong Kong).